Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Hydrocortisone in Patients With Severe H1N1 Related Pneumonia

NCT01014364 is registered in ClinicalTrials.gov with University of Versailles as lead sponsor.

NCT NCT01014364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Hydrocortisone in Patients With Severe H1N1 Related Pneumonia
Lead sponsor
University of Versailles
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2010
Completion date
December 31, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza in humans, pneumonia, viral